Research-grade reagents for Enterovirus 71 (EV71) — a picornavirus causing hand, foot, and mouth disease (HFMD) and severe neurological complications in children. VP1 is the key diagnostic and vaccine target, mediating viral attachment and tissue tropism. We offer recombinant/polyclonal/InVivoMAb antibodies, recombinant proteins, validated for ELISA, WB, IHC, FCM, IF, and neutralization assays. Comprehensive coverage of structural and non-structural proteins enables mechanistic studies of viral pathogenesis, immune response characterization, and vaccine antigen optimization. RUO
All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.
1. Knowlton JL, Derrick SC, Yang SJ, et al. Enterovirus 71 VP1 vaccination elicits broadly cross-neutralizing antibodies. J Virol. 2012;86(12):6841-6844. DOI
2. Solomon T, Lewthwaite P, Perera D, et al. Management of suspected viral encephalitis in adults. J Infect. 2012;64(4):347-373. DOI
3. Cabezas C, Fiestas V, García W, et al. Molecular epidemiology of human enterovirus 71 in Peru. PLoS One. 2013;8(8):e71432. DOI
4. Tung WS, Bakar SA, Sekawi Z, Rosli R. Enterovirus 71: A review of epidemiology, virology, clinical presentations and treatment. Arch Virol. 2014;159(12):3393-3403. DOI
Enterovirus 71 (EV71)
ELISA, FCM, IF, WB
Human
IgG1
D5
Enterovirus 71 (EV71)
ELISA, FCM, IP, Neutralization
Human
IgG1
SAA2027
E. coli
A0A894JU04
Gly1549-Phe2193
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Enterovirus 71 (EV71)
E. coli
A0A894JU04
Gly566-Leu862
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Enterovirus 71 (EV71)
Enterovirus 71 (EV71)
ELISA, IHC, WB
Rabbit
IgG
Enterovirus 71 (EV71)
ELISA, IP, Neutralization
Human
IgM
M1-20
Enterovirus 71 (EV71)
Neutralization
Human
IgG1
22A12
Enterovirus 71 (EV71)
Neutralization
Human
IgG1
E5RPG0
Enterovirus 71 (EV71)
Neutralization
Human
IgG1
A9
Enterovirus 71 (EV71)
Neutralization
Human
IgG1
D6